Organs

The Evolution Code Expands Its Nervous System Training Program Beyond Professional Athletes

Retrieved on: 
Wednesday, July 22, 2020
Animal anatomy, Brain, Organs, Human, Biological system, Animals, Zoology, Branches of biology

For nearly 40 years, The Evolution Code has prepared Olympic (or elite) athletes and professional sports teams around the world for competition using specific programming designed to retrain the nervous system the driver of all bodily systems.

Key Points: 
  • For nearly 40 years, The Evolution Code has prepared Olympic (or elite) athletes and professional sports teams around the world for competition using specific programming designed to retrain the nervous system the driver of all bodily systems.
  • The Evolution Code conditions the nervous system so the brain, the muscles, the organs, everything works together to achieve mastery over your own humanity.
  • The Evolution Code currently offers three program packages with varied pricing:
    CODE 1 Designed as an adjunct program to be used with any individuals existing heath/fitness program.
  • The Evolution Code has nearly 40 years of experience training athletes and fitness enthusiasts of all ages and levels by conditioning and correcting the nervous system.

Canon Medical Introduces New Configuration of Aquilion ONE / GENESIS Edition – A Comprehensive Cardiac CT Solution Powered by Artificial Intelligence

Retrieved on: 
Friday, July 17, 2020
Medical devices, Hospitals, Health, Radiology, Cardiology, RTT, Heart, Organs, Magnetic resonance imaging, Human anatomy, Branches of biology, Canon Medical Systems USA, Inc., Canon Medical Systems Corporation

To meet the growing cardiovascular imaging needs of healthcare systems, Canon Medical Systems USA, Inc. is introducing a new configuration of the Aquilion ONE / GENESIS Edition the Aquilion ONE / GENESIS SP a complete CT solution with proven cardiovascular capabilities.

Key Points: 
  • To meet the growing cardiovascular imaging needs of healthcare systems, Canon Medical Systems USA, Inc. is introducing a new configuration of the Aquilion ONE / GENESIS Edition the Aquilion ONE / GENESIS SP a complete CT solution with proven cardiovascular capabilities.
  • The Aquilion ONE / GENESIS SP was designed for the evolving needs of structural and coronary imaging, enabling consistent, high-quality studies through its AI-powered wide-area CT.
  • The Aquilion ONE / GENESIS SP enhances Canon Medicals suite of Collaborative imaging tools which deliver clarity and confidence across the patient care cycle.
  • Due to expanding applications of CT for structural heart procedures and coronary imaging, healthcare providers are growing their cardiac CT programs.

Bob Harper and AstraZeneca Bring Virtual Series to Heart Attack Survivors to Inspire Others with Stories About Second Chances

Retrieved on: 
Wednesday, July 15, 2020
Entertainment, Health, General Entertainment, General Health, Pharmaceutical, Cardiology, Heart, Organs, RTT, Survivors Have Heart, Bob Harper, AstraZeneca

This year, through a series of virtual meetings and live stream events, Survivors Have Heart and Bob Harper host of The Biggest Loser, best-selling author and heart attack survivor will focus on empowering heart attack survivors to use their second chance at life to share their inspiring stories and expand the Survivors Have Heart community.

Key Points: 
  • This year, through a series of virtual meetings and live stream events, Survivors Have Heart and Bob Harper host of The Biggest Loser, best-selling author and heart attack survivor will focus on empowering heart attack survivors to use their second chance at life to share their inspiring stories and expand the Survivors Have Heart community.
  • With everything going on in our world, now more than ever seemed like an important time to reach heart attack survivors and connect with them through Survivors Have Heart.
  • Im so proud of the work were doing to educate about the risk of having another heart attack and provide heart attack survivors the opportunity to learn from and inspire each other.
  • Survivors Have Heart is a national movement that uses the power of patient stories to engage heart attack survivors and their loved ones, while supporting those who may be at risk of another heart attack.

MacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric Cancer

Retrieved on: 
Thursday, July 9, 2020
Abdomen, RTT, Digestive system, Organs, Medical specialties, Organ systems, Medicine, Stomach, Cancer, Esophagus, Oncology, Andecaliximab

The Phase 2 study enrolled patients with gastric cancer (GC) or gastroesophageal junction (GEJ) cancer whose tumors were IHC3-positive or IHC2-positive/FISH-positive at diagnosis.

Key Points: 
  • The Phase 2 study enrolled patients with gastric cancer (GC) or gastroesophageal junction (GEJ) cancer whose tumors were IHC3-positive or IHC2-positive/FISH-positive at diagnosis.
  • The data published in Lancet Oncology are reported as of July 10, 2019 and were presented at the European Society for Medical Oncology (ESMO) Annual Congress in September 2019.
  • Cancer of the stomach (gastric cancer) or the gastroesophageal junction (where the esophagus joins the stomach) is collectively known as gastroesophageal adenocarcinoma.
  • MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer.

Azitra Awarded U.S. Composition of Matter Patent Covering Engineered Bacterial Strains for Treating Skin Conditions

Retrieved on: 
Tuesday, July 7, 2020
Biotechnology, Pharmaceutical, Health, Clinical trials, Branches of biology, Microbiology, Organisms, Bacteriology, Organs, Microbiomes, Gram-positive bacteria, Human skin, Staphylococcus epidermidis, Bacteria, Skin, Strain

The patent includes broad composition of matter claims that cover the Companys engineered bacterial strain discovery platform, are central to its programs for treating skin diseases, and provide a significant barrier to entry for competitors.

Key Points: 
  • The patent includes broad composition of matter claims that cover the Companys engineered bacterial strain discovery platform, are central to its programs for treating skin diseases, and provide a significant barrier to entry for competitors.
  • One key allowed claim covered under the patent includes the pharmaceutical composition comprising selected bacterial strains and at least one engineered bacterial strain that produces a therapeutically active protein for treating abnormal human skin conditions.
  • Our proprietary discovery platform combines the properties of the skin microbiome with therapeutic protein expression to address serious skin conditions and diseases.
  • Azitras auxotrophic strain strategy allows the Company to both select S. epidermidis strains and control its growth on the skin.

NextMind: Time to Put Your Brain in Gear

Retrieved on: 
Tuesday, June 30, 2020
Science, Software, Other Science, Audio, Video, Hardware, Consumer electronics, Technology, Other Technology, Animal anatomy, Brain, Organs, Emerging technologies, Branches of biology, Neurotechnology, Neuroprosthetics, Zoology, Neuroscience

NextMind allows users to let their brain take control of their digital world.

Key Points: 
  • NextMind allows users to let their brain take control of their digital world.
  • NextMinds device is a small, lightweight wearable that captures electrical brain signals from the users visual cortex to create a deeper, more immersive experience between human and computer.
  • NextMind SDK: Ready-to-use Unity resources such as tutorials, brain game use cases, demonstrations and code building blocks.
  • Thousands of event attendees personally experienced the way NextMind allows users to unlock the sixth sense of direct-brain commands.

Brain Armor Launches Innovative Gut-Brain Formula

Retrieved on: 
Thursday, June 18, 2020
Animal anatomy, Brain, Organs, Cranberry, Branches of biology, Organisms, Plants

Because of the important connection between your brain and gut, we wanted a product in the Brain Armor line up that could support and maintain the health of this connectivity.But why cranberries?

Key Points: 
  • Because of the important connection between your brain and gut, we wanted a product in the Brain Armor line up that could support and maintain the health of this connectivity.But why cranberries?
  • So, we combined cranberry extract with the best pre and pro-biotics resulting in a Gut-Brain formula that promotes digestive and brain health.
  • Brain Armor is on a mission to improve cognitive health, well-being and performance at every stage of life and on every field of play.
  • Brain Armor products are vegetarian, made in the USA and are a regular part of many professional and elite amateur athlete and team conditioning programs.

Global Thymus Cancer Market Insights by Cancer Type, Treatment, End-user and Region (2017-2025)

Retrieved on: 
Monday, June 15, 2020
Medical specialties, Animal anatomy, Statistical forecasting, Organ systems, Immune system, Lymphatic system, Mammal anatomy, Organs, Thymus, Forecasting

The report predicts the global thymus cancer market to grow with a CAGR of 5.4% over the forecast period from 2019-2025.

Key Points: 
  • The report predicts the global thymus cancer market to grow with a CAGR of 5.4% over the forecast period from 2019-2025.
  • The report on the global thymus cancer market provides qualitative and quantitative analysis for the period from 2017 to 2025.
  • The report on thymus cancer market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global thymus cancer market over the period of 2017 to 2025.
  • Complete coverage of all the segments in the thymus cancer market to analyze the trends, developments in the global market and forecast of market size up to 2025.

Thymus Cancer Market: Analysis, Trends, Size and Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 10, 2020
Surgery, Health, Radiology, Pharmaceutical, Oncology, Medical specialties, Statistical forecasting, Animal anatomy, Organ systems, Immune system, Lymphatic system, Mammal anatomy, Organs, Thymus, Forecasting

The "Thymus Cancer Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Thymus Cancer Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The report on the global thymus cancer market provides qualitative and quantitative analysis for the period from 2017 to 2025.
  • The report on thymus cancer market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global thymus cancer market over the period of 2017 to 2025.
  • Complete coverage of all the segments in the thymus cancer market to analyze the trends, developments in the global market and forecast of market size up to 2025.

First-of-Its-Kind Human Tissue Study Finds Link Between NAD Decline and Alcohol-Related Liver Disease (ArLD)

Retrieved on: 
Wednesday, June 3, 2020
MEN, Research, Other Health, Consumer, Fitness & Nutrition, Clinical trials, Science, Biotechnology, Women, Alternative medicine, Seniors, Health, Other Science, Branches of biology, Metabolism, Systems biology, Medical specialties, Liver, Organs, Metabolome, Biology, Hepatology

This is the first study to evaluate the NAD metabolome in human liver samples.

Key Points: 
  • This is the first study to evaluate the NAD metabolome in human liver samples.
  • This new study assessed the NAD metabolome in transplant and tissue resections from 72 patients with ArLD or four other conditions.
  • Analysis of liver tissue from the 43 ArLD patients showed marked depletion of NAD and its precursors.
  • Depressed NAD levels correlated with low markers of liver function, suggesting that liver NAD status is important for human health.